218 related articles for article (PubMed ID: 29876904)
1. Prognostic significance of anterior mitral valve leaflet length in individuals with a hypertrophic cardiomyopathy gene mutation without hypertrophic changes.
van Velzen HG; Schinkel AFL; Menting ME; van den Bosch AE; Michels M
J Ultrasound; 2018 Sep; 21(3):217-224. PubMed ID: 29876904
[TBL] [Abstract][Full Text] [Related]
2. Anterior mitral valve leaflet length in cats with hypertrophic cardiomyopathy.
Seo J; Matos JN; Payne JR; Fuentes VL; Connolly DJ
J Vet Cardiol; 2021 Oct; 37():62-70. PubMed ID: 34610570
[TBL] [Abstract][Full Text] [Related]
3. Systolic anterior motion of the anterior mitral valve leaflet begins in subclinical hypertrophic cardiomyopathy.
Seitler S; De Zoysa Anthony S; Obianyo CCC; Syrris P; Patel V; Sado DM; Maestrini V; Castelletti S; Walsh S; O'Brien B; Moon JC; Captur G
Eur Heart J Cardiovasc Imaging; 2023 Dec; 25(1):86-94. PubMed ID: 37523765
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular magnetic resonance of mitral valve length in hypertrophic cardiomyopathy.
Tarkiainen M; Sipola P; Jalanko M; Heliö T; Laine M; Järvinen V; Häyrinen K; Lauerma K; Kuusisto J
J Cardiovasc Magn Reson; 2016 Jun; 18(1):33. PubMed ID: 27259862
[TBL] [Abstract][Full Text] [Related]
5. Genetic relevance and determinants of mitral leaflet size in hypertrophic cardiomyopathy.
Chung H; Kim Y; Park CH; Kim JY; Min PK; Yoon YW; Kim TH; Lee BK; Hong BK; Rim SJ; Kwon HM; Lee KA; Choi EY
Cardiovasc Ultrasound; 2019 Oct; 17(1):21. PubMed ID: 31660989
[TBL] [Abstract][Full Text] [Related]
6. Contribution of mitral valve leaflet length and septal wall thickness to outflow tract obstruction in patients with hypertrophic cardiomyopathy.
Morant K; Mikami Y; Nevis I; McCarty D; Stirrat J; Scholl D; Rajchl M; Giannoccaro P; Kolman L; Heydari B; Lydell C; Howarth A; Grant A; White JA
Int J Cardiovasc Imaging; 2017 Aug; 33(8):1201-1211. PubMed ID: 28391581
[TBL] [Abstract][Full Text] [Related]
7. Intrinsic mitral valve alterations in hypertrophic cardiomyopathy sarcomere mutation carriers.
Groarke JD; Galazka PZ; Cirino AL; Lakdawala NK; Thune JJ; Bundgaard H; Orav EJ; Levine RA; Ho CY
Eur Heart J Cardiovasc Imaging; 2018 Oct; 19(10):1109-1116. PubMed ID: 30052928
[TBL] [Abstract][Full Text] [Related]
8. Abnormal Mitral Valve Dimensions in Pediatric Patients with Hypertrophic Cardiomyopathy.
Schantz D; Benson L; Windram J; Wong D; Dragulescu A; Yoo SJ; Mertens L; Friedberg M; Al Nafisi B; Grosse-Wortmann L
Pediatr Cardiol; 2016 Apr; 37(4):784-8. PubMed ID: 26961572
[TBL] [Abstract][Full Text] [Related]
9. Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy Patients Without Severe Septal Hypertrophy: Implications of Mitral Valve and Papillary Muscle Abnormalities Assessed Using Cardiac Magnetic Resonance and Echocardiography.
Patel P; Dhillon A; Popovic ZB; Smedira NG; Rizzo J; Thamilarasan M; Agler D; Lytle BW; Lever HM; Desai MY
Circ Cardiovasc Imaging; 2015 Jul; 8(7):e003132. PubMed ID: 26082555
[TBL] [Abstract][Full Text] [Related]
10. Ultrasonic Assessment of Myocardial Microstructure in Hypertrophic Cardiomyopathy Sarcomere Mutation Carriers With and Without Left Ventricular Hypertrophy.
Hiremath P; Lawler PR; Ho JE; Correia AW; Abbasi SA; Kwong RY; Jerosch-Herold M; Ho CY; Cheng S
Circ Heart Fail; 2016 Sep; 9(9):. PubMed ID: 27623770
[TBL] [Abstract][Full Text] [Related]
11. Morphological and functional abnormalities pattern in hypertrophy-free HCM mutation carriers detected with echocardiography.
Peyrou J; Réant P; Reynaud A; Cornolle C; Dijos M; Rooryck-Thambo C; Landelle M; Montaudon M; Laurent F; Roudaut R; Lafitte S
Int J Cardiovasc Imaging; 2016 Sep; 32(9):1379-1389. PubMed ID: 27324645
[TBL] [Abstract][Full Text] [Related]
12. Five-year prognostic significance of global longitudinal strain in individuals with a hypertrophic cardiomyopathy gene mutation without hypertrophic changes.
van Velzen HG; Schinkel AFL; van Grootel RWJ; van Slegtenhorst MA; van der Velden J; Strachinaru M; Michels M
Neth Heart J; 2019 Mar; 27(3):117-126. PubMed ID: 30680638
[TBL] [Abstract][Full Text] [Related]
13. Mitral valve abnormalities identified by cardiovascular magnetic resonance represent a primary phenotypic expression of hypertrophic cardiomyopathy.
Maron MS; Olivotto I; Harrigan C; Appelbaum E; Gibson CM; Lesser JR; Haas TS; Udelson JE; Manning WJ; Maron BJ
Circulation; 2011 Jul; 124(1):40-7. PubMed ID: 21670234
[TBL] [Abstract][Full Text] [Related]
14. Utility of the posterior to anterior mitral valve leaflets length ratio in prediction of outcome of percutaneous balloon mitral valvuloplasty.
Mahfouz RA
Echocardiography; 2011 Nov; 28(10):1068-73. PubMed ID: 21966895
[TBL] [Abstract][Full Text] [Related]
15. Echocardiographic evaluation of pre-diagnostic development in young relatives genetically predisposed to hypertrophic cardiomyopathy.
Jensen MK; Havndrup O; Christiansen M; Andersen PS; Axelsson A; Køber L; Bundgaard H
Int J Cardiovasc Imaging; 2015 Dec; 31(8):1511-8. PubMed ID: 26231341
[TBL] [Abstract][Full Text] [Related]
16. Early changes in apical rotation in genotype positive children with hypertrophic cardiomyopathy mutations without hypertrophic changes on two-dimensional imaging.
Forsey J; Benson L; Rozenblyum E; Friedberg MK; Mertens L
J Am Soc Echocardiogr; 2014 Feb; 27(2):215-21. PubMed ID: 24325958
[TBL] [Abstract][Full Text] [Related]
17. Abnormal septal convexity into the left ventricle occurs in subclinical hypertrophic cardiomyopathy.
Reant P; Captur G; Mirabel M; Nasis A; M Sado D; Maestrini V; Castelletti S; Manisty C; Herrey AS; Syrris P; Tome-Esteban M; Jenkins S; Elliott PM; McKenna WJ; Moon JC
J Cardiovasc Magn Reson; 2015 Jul; 17(1):64. PubMed ID: 26219660
[TBL] [Abstract][Full Text] [Related]
18. Mitral annular plane systolic excursion is an easy tool for fibrosis detection by late gadolinium enhancement cardiovascular magnetic resonance imaging in patients with hypertrophic cardiomyopathy.
Doesch C; Sperb A; Sudarski S; Lossnitzer D; Rudic B; Tülümen E; Heggemann F; Schimpf R; Schoenberg SO; Borggrefe M; Papavassiliu T
Arch Cardiovasc Dis; 2015; 108(6-7):356-66. PubMed ID: 25863428
[TBL] [Abstract][Full Text] [Related]
19. Assessment of mitral valve function in children and young adults with hypertrophic cardiomyopathy using three-dimensional echocardiography.
Joseph N; Craft M; Mill L; Erickson CC; Danford DA; Kutty S; Li L
Int J Cardiol; 2021 Jun; 332():182-188. PubMed ID: 33753187
[TBL] [Abstract][Full Text] [Related]
20. Penetrance of Hypertrophic Cardiomyopathy in Sarcomere Protein Mutation Carriers.
Lorenzini M; Norrish G; Field E; Ochoa JP; Cicerchia M; Akhtar MM; Syrris P; Lopes LR; Kaski JP; Elliott PM
J Am Coll Cardiol; 2020 Aug; 76(5):550-559. PubMed ID: 32731933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
